Changing Concepts of "Latent Tuberculosis Infection" in Patients Living with HIV Infection
Author(s)
Lawn, SD
Wood, R
Wilkinson, RJ
Type
Journal Article
Abstract
One third of the world’s population is estimated to be infected with
Mycobacterium tuberculosis
, representing a huge reservoir
of potential tuberculosis (TB) disease. Risk of progression to active TB is highest in those with HIV coinfection. However, the
nature of the host-pathogen relationship in those with “latent TB infection” and how this is a
ff
ected by HIV coinfection are poorly
understood. The traditional paradigm that distinguishes latent
infection from active TB as distinct compartmentalised states is
overly simplistic. Instead the host-pathogen relationship in “latent TB infection” is likely to represent a spectrum of immune
responses, mycobacterial metabolic activity, and bacillary nu
mbers. We propose that the impact of HIV infection might better
be conceptualised as a shift of the spectrum towards poor immune co
ntrol, higher mycobacterial metabolic activity, and greater
organism load, with subsequent increased risk of progression to active disease. Here we discuss the evidence for such a model and
the implications for interventions to control the HIV-associated TB epidemic.
Mycobacterium tuberculosis
, representing a huge reservoir
of potential tuberculosis (TB) disease. Risk of progression to active TB is highest in those with HIV coinfection. However, the
nature of the host-pathogen relationship in those with “latent TB infection” and how this is a
ff
ected by HIV coinfection are poorly
understood. The traditional paradigm that distinguishes latent
infection from active TB as distinct compartmentalised states is
overly simplistic. Instead the host-pathogen relationship in “latent TB infection” is likely to represent a spectrum of immune
responses, mycobacterial metabolic activity, and bacillary nu
mbers. We propose that the impact of HIV infection might better
be conceptualised as a shift of the spectrum towards poor immune co
ntrol, higher mycobacterial metabolic activity, and greater
organism load, with subsequent increased risk of progression to active disease. Here we discuss the evidence for such a model and
the implications for interventions to control the HIV-associated TB epidemic.
Date Issued
2011-01-01
ISSN
1740-2522
Publisher
Hindawi Publishing Corporation
Journal / Book Title
Clinical & Developmental Immunology
Copyright Statement
© 2011 Stephen D. Lawn et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and repro
duction in any medium, provided the original work is properly
cited.
License, which permits unrestricted use, distribution, and repro
duction in any medium, provided the original work is properly
cited.
Identifier
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000283222400001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
Subjects
Science & Technology
Life Sciences & Biomedicine
Immunology
IMMUNOLOGY
HUMAN-IMMUNODEFICIENCY-VIRUS
RESOURCE-LIMITED SETTINGS
ACTIVE ANTIRETROVIRAL THERAPY
ISONIAZID PREVENTIVE THERAPY
IMMUNE RECONSTITUTION DISEASE
SOUTH-AFRICA
PULMONARY TUBERCULOSIS
MYCOBACTERIUM-TUBERCULOSIS
OPPORTUNISTIC INFECTIONS
RIFAMPIN RESISTANCE
AIDS-Related Opportunistic Infections
Epidemics
HIV Infections
HIV-1
Host-Pathogen Interactions
Humans
Latent Tuberculosis
Models, Biological
Mycobacterium tuberculosis
Tuberculosis
1107 Immunology
Publication Status
Published
Article Number
ARTN 980594